StreetAlpha.app
Home › Stocks › ACOG

Alpha Cognition Inc. (ACOG)

Members
LATEST PRICE

Alpha Cognition develops and sells ZUNVEYL, an oral tablet for Alzheimer's disease. ACOG reports earnings on Thu, Nov 12, 2026.

Prices, price targets and earnings estimates for ACOG are shown to AI Starter and AI Pro members. Ratings, flow and news are open to everyone.See plans
AI Auto Pilots
Is ACOG in one of our four AI portfolios? Sign in free to see
See how it works→ Details ↓

Earnings

Earnings calendar →
Next report
Nov 12
2026 · Time not announced
Consensus EPS forecast
Members
EPS and revenue estimates
Year-ago EPS
Members
Same quarter last year
Options-implied move
Members
Move priced in by options
Analyst consensus
2 Buy
2 firms · not enough for a consensus
Loading…

Analyst Ratings & Price Targets

Analyst Ratings →
Ratings · 90 days
2 Buy
2firms
2 Buy0 Hold0 Sell
Only 2 firms rated ACOG in the past 90 days, not enough for a consensus
Average 12-month target
Price targets for ACOGThe average, highest and lowest analyst targets and the target chart are shown to AI Starter and AI Pro members.See plans
Latest rating changes
B. Riley SecuritiesInitiated
Aug 20Buy
HC Wainwright & Co.Maintained
Aug 17Buy
Raymond JamesInitiated
Jul 10Buy
Maxim GroupInitiated
May 29Buy
Craig-HallumInitiated
Apr 17Buy
DateFirmActionRatingPrice target
Aug 20B. Riley SecuritiesInitiatedBuy
Aug 17HC Wainwright & Co.MaintainedBuy
Jul 10Raymond JamesInitiatedBuy
May 29Maxim GroupInitiatedBuy
Apr 17Craig-HallumInitiatedBuy
Loading…

Whale Options Flow

90D

No whale options trades in ACOG in the last 90 days.

Loading…

AI Auto Pilots

Paper trading

StreetAlpha runs four autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether ACOG is in one of them and how their past ACOG trades turned out.

See how it works→ View all auto pilots→
ACOG in the AI portfolios
Loading…

Macro & Market News

All StreetAlpha news →

StreetAlpha hasn't covered ACOG in an article yet. Here's the latest on the wider market.

macronewsFriday, October 30, 2026
Binance and Polymarket Hacks Test Crypto's Plumbing, Not Yet Macro
Binance paused withdrawals after a suspected theft of roughly $6 billion, while Polymarket halted trading for an hour after a vendor breach.
Jean Westart · 3 min read
macronewsMonday, October 26, 2026
S&P 500 Sits 2.5% Below Its Record Ahead of the Fed and Big Tech
The S&P 500 slipped 0.47% to 7,623.68, 2.5% below its record, as the Fed meets October 28 and Alphabet, Microsoft and Amazon report.
Marie Crown · 3 min read
macronewsMonday, October 26, 2026
Hightower's Stephanie Link Tells Investors to Add on Volatility
Hightower's Stephanie Link told CNBC's Squawk Box that investors should use market volatility to add to portfolios as earnings season unfolds.
Adam Landser · 2 min read

About Alpha Cognition

Alpha Cognition is a biopharmaceutical company based in Grapevine, Texas, that develops treatments for neurodegenerative diseases, with a focus on Alzheimer's disease. Its main product is ZUNVEYL, an oral tablet for mild to moderate dementia of the Alzheimer's type. The company sells ZUNVEYL to nursing homes that care for Alzheimer's patients, working with physicians, pharmacies and pharmacy benefit managers to expand access. It also has earlier stage programs and has licensed ZUNVEYL rights in parts of Asia, Australia and New Zealand.

Headquarters
Grapevine, TX
Summary based on the company’s 2026 annual report (10-K) ↗